Login / Signup

Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma.

Slavisa NinkovicSimon J HarrisonHang Quach
Published in: Expert review of hematology (2020)
Cell-surface GRP78 expression is a potential novel prognostic biomarker in myeloma and targeting of csGRP78 is promising and requires further investigation.
Keyphrases